Ustekinumab Ttwe — Carefirst Caremark
5 indications indexed for this drug.
- Active Psoriatic Arthritis PsaView coverage criteria
- Immune Checkpoint Inhibitor Related ToxicityView coverage criteria
- Moderate To Severe Plaque Psoriasis PsoView coverage criteria
- Moderately To Severely Active Crohn S Disease CdView coverage criteria
- Moderately To Severely Active Ulcerative Colitis UcView coverage criteria